BROMOCRIPTINE DOSE AND SEVERITY OF PARKINSONS-DISEASE

被引:0
|
作者
GRIMES, JD
机构
关键词
D O I
10.1212/WNL.35.4.614-a
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:614 / 615
页数:2
相关论文
共 50 条
  • [21] BROMOCRIPTINE INDUCED IMPOTENCE IN PARKINSONS-DISEASE
    CLEEVES, L
    FINDLEY, LJ
    [J]. BRITISH MEDICAL JOURNAL, 1987, 295 (6594): : 367 - 368
  • [22] BROMOCRIPTINE AND THE CLINICAL SPECTRUM OF PARKINSONS-DISEASE
    RIOPELLE, RJ
    [J]. CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1987, 14 (03) : 455 - 459
  • [23] ADJUNCTIVE THERAPY WITH BROMOCRIPTINE IN PARKINSONS-DISEASE
    TEMLETT, JA
    MING, A
    SALING, M
    FRITZ, VU
    BLUMENFELD, A
    BILCHIK, TR
    BECKER, AL
    FOURIE, PB
    REEF, HE
    [J]. SOUTH AFRICAN MEDICAL JOURNAL, 1990, 78 (11): : 680 - 685
  • [24] THE CONTROVERSIAL ROLE OF BROMOCRIPTINE IN PARKINSONS-DISEASE
    HARDIE, RJ
    LEES, AJ
    STERN, GM
    [J]. CLINICAL NEUROPHARMACOLOGY, 1985, 8 (02) : 150 - 155
  • [25] TREATMENT OF PARKINSONS-DISEASE WITH BROMOCRIPTINE - REPLY
    LIEBERMAN, AN
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1977, 297 (09): : 508 - 509
  • [26] BROMOCRIPTINE IN LIEU OF LEVODOPA FOR PARKINSONS-DISEASE
    WODAK, J
    STARK, R
    GILLIGAN, B
    [J]. MEDICAL JOURNAL OF AUSTRALIA, 1978, 2 : 28 - 31
  • [27] BROMOCRIPTINE - PROBLEMS WITH LOW-DOSE DENOVO THERAPY IN PARKINSONS-DISEASE
    GRIMES, JD
    DELGADO, MR
    [J]. CLINICAL NEUROPHARMACOLOGY, 1985, 8 (01) : 73 - 77
  • [28] LOW-DOSE BROMOCRIPTINE ADDED TO LEVODOPA IN THE TREATMENT OF PARKINSONS-DISEASE
    MASSETANI, R
    PICCINI, P
    MURRI, L
    MURATORIO, A
    [J]. CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1989, 46 (02): : 210 - 215
  • [29] THE INFLUENCE OF LEVODOPA IN THE PHARMACOKINETICS OF BROMOCRIPTINE IN PARKINSONS-DISEASE
    RABEY, JM
    OBERMAN, Z
    SCHARF, M
    ISAKOV, A
    BAR, M
    GRAFF, E
    [J]. CLINICAL NEUROPHARMACOLOGY, 1989, 12 (05) : 440 - 447
  • [30] THE INFLUENCE OF BROMOCRIPTINE ON THE PHARMACOKINETICS OF LEVODOPA IN PARKINSONS-DISEASE
    RABEY, JM
    SCHWARTZ, M
    GRAFF, E
    HARSAT, A
    VERED, Y
    [J]. CLINICAL NEUROPHARMACOLOGY, 1991, 14 (06) : 514 - 522